Leading efforts to translate research into treatments at the NIH had felt, for physician Josh Fessel, like the way he could ...

Patients want to know, “When should I get an mpox vaccine booster?” But the research to answer their question isn’t available ...

The rise of anti-science and anti-vaccine rhetoric has fundamentally changed the relationship between clinicians and patients.” ...

Study points to source of "very, very rare" cases of myocarditis and potential solutions. Myocarditis risk remains far higher ...

Care for patients with dementia has changed radically since Jason Karlawish started working in the field in the late ’90s, he ...

Health system lawyers are silent on why hospitals don't keep AI scribe transcripts for quality and accuracy research.

In a closely watched case, the U.S. solicitor general urged the Supreme Court to review a controversy over so-called skinny ...

Deputy health secretary Jim O’Neill demurred when asked about a proposal to prevent states from enforcing local AI laws.

High costs, quiet-period rules, investor skepticism, and lingering safety concerns are pushing major insurers to once again ...

Morning! Today, we preview a contentious generic drug dispute that may end up at the Supreme Court, discuss how the FDA’s new ...

Congress is poised to pass the Biosecure Act after two years of incremental changes that watered down the bill’s curbs on Chinese biotechs ...

The Food and Drug Administration this week granted approval to a new gene therapy for a rare immune disorder, the maker of which is notably not a drug ...